A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
National Cancer Center
Gyeonggi-do, Goyang-si, South Korea
RECRUITINGChonnam National University Hwasun Hospital
Jeollanam-do, Hwasun-gun, South Korea
RECRUITINGJeonbuk National University Hospital
Jeollabuk-do, Jeonju-si, South Korea
Occurance rate of adverse drug reaction
Time frame: Day 1 to day 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Severance Hospital
Seoul, Seodaemun-gu, South Korea
RECRUITINGSeoul National University Bundang
Gyeonggi-do, Seongnam-si, South Korea
RECRUITING